Error loading player: No playable sources found

T32

Clostridium Difficile: An Organism with a New Virulence

Date
January 24, 2012
Credits
1.5 Dietitian | 1.5 Nurse | 1.5 Pharmacist | 1.5 Physician | 1.5 Other | Expired April 1, 2016

  1. Summarize the etiology and pathogenesis of C. Difficile infections
  2. Distinguish among selective pharmaceutical agents that predispose patients to C. Difficile colitis
  3. Define the unique risk factors for patients with inflammatory bowel disease and C. Difficile infections and their treatment challenges

Speakers

Speaker Image for Deborah Andris
Nurse Practitioner, Division of Colorectal Surgery, Medical College of Wisconsin, Milwaukee, WI
Speaker Image for Todd Canada
Todd Canada, PharmD, BCNSP, BCCCP, FASHP, FTSHP, FASPEN
Clinical Pharmacy Services Manager & Nutrition Support Team Coordinator, University of Texas MD Anderson Cancer Center, Houston, TX
Speaker Image for Charles Edmiston
Speaker Image for Heidi Bahna

Related Products

Thumbnail for Parenteral Nutrition in the Adult Oncology Population
Parenteral Nutrition in the Adult Oncology Population
Parenteral nutrition (PN) is a complex therapy managed by an interprofessional healthcare team. PN can be an invaluable support for select patients undergoing anticancer treatment…

Copyright © 2025 American Society for Parenteral and Enteral Nutrition
Powered by Conexiant DXP
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.